论文部分内容阅读
目的观察茵虎汤联合西药治疗中晚期原发性肝癌的临床疗效。方法将50例中晚期原发性肝癌患者按照随机数字表法随机分成两组,每组各25例,对照组给予保肝及对症支持治疗,治疗组在对照组治疗基础上加服茵虎汤(茵陈、虎杖、郁金、丹参、赤芍、半枝莲、白花蛇舌草、灵芝、山豆根、佛手、白术、茯苓),1日1剂,分2次口服。两组均以治疗60日为1个疗程。结果治疗组近期疗效改善率显著高于对照组;2年生存率亦均明显高于对照组;治疗后肝功能指标和总胆红素明显降低,且明显低于对照组。两组对比,差别有统计学意义(P<0.01)。结论茵虎汤联合西药治疗中晚期原发性肝癌疗效显著,值得临床推广应用。
Objective To observe the clinical efficacy of Yinhu Decoction combined with western medicine in the treatment of advanced primary liver cancer. Methods Fifty patients with primary hepatocellular carcinoma (HCC) were randomly divided into two groups (n = 25 in each group). The control group was given hepatoprotective and symptomatic supportive treatment. The treatment group was given Yinhu decoction (Capillaris, Polygonum cuspidatum, tulip, Salvia, red peony root, Scutellaria barbata, Hedyotis diffusa, Ganoderma lucidum, root of bean, bergamot, Atractylodes, Poria), on the 1st of 1, 2 times orally. Both groups were treated for 60 days as a course of treatment. Results The improvement rate of the curative effect in the treatment group was significantly higher than that in the control group. The 2-year survival rate was also significantly higher than that of the control group. The liver function index and total bilirubin were significantly decreased after treatment, which were significantly lower than those in the control group. The difference between the two groups was statistically significant (P <0.01). Conclusions Yin Hu decoction combined with Western medicine in the treatment of advanced primary liver cancer has significant curative effect and is worthy of clinical application.